Difference between revisions of "CAR T-cell toxicity management"
Jump to navigation
Jump to search
m (Text replacement - "[[Media:" to "[[File:") |
m |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | ''' | + | '''<big>This page is in process of being created.''' For preparatory regimens for CAR T-cell therapy, please go to [[Chimeric antigen receptor T cells (CAR-T)|this page]].</big> |
{{TOC limit|limit=4}} | {{TOC limit|limit=4}} | ||
| Line 5: | Line 5: | ||
===CTCAE=== | ===CTCAE=== | ||
*[http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC)] - Adverse event grading for clinical trials<ref>[http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC)] - Adverse event grading for clinical trials</ref> | *[http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC)] - Adverse event grading for clinical trials<ref>[http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC)] - Adverse event grading for clinical trials</ref> | ||
| − | :*[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf CTCAE 5x7" small booklet format] [[File:CTCAE4 5x7.pdf|local backup]]<ref>[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf CTCAE 5x7" small booklet format] [[File:CTCAE4 5x7.pdf|local backup]]</ref> | + | :*[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf CTCAE 5x7" small booklet format] [[:File:CTCAE4 5x7.pdf|local backup]]<ref>[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf CTCAE 5x7" small booklet format] [[:File:CTCAE4 5x7.pdf|local backup]]</ref> |
| − | :*[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf CTCAE 8.5x11" letter size format] [[File:CTCAE4 8.5x11.pdf|local backup]]<ref>[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf CTCAE 8.5x11" letter size format] [[File:CTCAE4 8.5x11.pdf|local backup]]</ref> | + | :*[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf CTCAE 8.5x11" letter size format] [[:File:CTCAE4 8.5x11.pdf|local backup]]<ref>[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf CTCAE 8.5x11" letter size format] [[:File:CTCAE4 8.5x11.pdf|local backup]]</ref> |
| − | |||
=='''Evaluation'''== | =='''Evaluation'''== | ||
| Line 16: | Line 15: | ||
[[Category:General reference pages]] | [[Category:General reference pages]] | ||
| − | [[Category:Supportive | + | [[Category:Supportive oncology]] |
| − | |||
Latest revision as of 14:26, 11 October 2023
This page is in process of being created. For preparatory regimens for CAR T-cell therapy, please go to this page.
Grading toxicity
CTCAE
- Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC) - Adverse event grading for clinical trials[1]
Evaluation
Management
References
- ↑ Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC) - Adverse event grading for clinical trials
- ↑ CTCAE 5x7" small booklet format local backup
- ↑ CTCAE 8.5x11" letter size format local backup